GE HealthCare expands dense breast screening portfolio with Invenia ABUS Prime and ABUS StreamVue
GE HealthCare launches Invenia ABUS Prime and ABUS StreamVue, targeting scalable dense breast screening and enterprise-wide review.
GE HealthCare launches Invenia ABUS Prime and ABUS StreamVue, targeting scalable dense breast screening and enterprise-wide review.
GE HealthCare has dosed the first patient in its LUMINA trial for mangaciclanol. Read why this MRI contrast milestone could reshape imaging markets.
GE HealthCare’s Photonova Spectra just won FDA clearance. Find out what this means for photon-counting CT, imaging workflows, and hospital adoption.
When GE HealthCare and NXP Semiconductors N.V. took the stage at CES 2026 to showcase their collaboration, it marked more than a moment of tech theater. The partnership unveiled two forward-looking concept technologies that aim to apply edge artificial intelligence to some of the most demanding environments in medicine: the operating room and the neonatal
GE HealthCare and Tribun Health join forces to unify cancer diagnostics at Sant’ Andrea Hospital. See how digital pathology is reshaping oncology workflows.